Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion type Assertion NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_head.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion description "[GAP-43 is preferentially reduced in the CSF of neurological disorders associated with neurodegeneration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_provenance.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion evidence source_evidence_literature NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_provenance.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion SIO_000772 25175067 NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_provenance.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion wasDerivedFrom befree-20150227 NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_provenance.
- NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_assertion wasGeneratedBy ECO_0000203 NP530947.RA5rWLWHExvnb2Tzch5MhWOlJbkjigqHTpkXW4OoXiQdA130_provenance.